News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
652,807 Results
Type
Article (44421)
Company Profile (171)
Press Release (608215)
Multimedia
Podcasts (77)
Webinars (12)
Section
Business (188255)
Career Advice (2582)
Deals (33536)
Drug Delivery (111)
Drug Development (79705)
Employer Resources (150)
FDA (15262)
Job Trends (14193)
News (324959)
Policy (31726)
Tag
Academia (2636)
Academic (1)
Accelerated approval (5)
Adcomms (27)
Allergies (79)
Alliances (46561)
ALS (96)
Alzheimer's disease (1419)
Antibody-drug conjugate (ADC) (136)
Approvals (15255)
Artificial intelligence (266)
Autoimmune disease (23)
Automation (16)
Bankruptcy (337)
Best Places to Work (10956)
BIOSECURE Act (17)
Biosimilars (103)
Biotechnology (97)
Bladder cancer (81)
Brain cancer (28)
Breast cancer (271)
Cancer (2225)
Cardiovascular disease (188)
Career advice (2182)
Career pathing (34)
CAR-T (147)
Cell therapy (417)
Cervical cancer (17)
Clinical research (64956)
Collaboration (791)
Compensation (411)
Complete response letters (26)
COVID-19 (2560)
CRISPR (42)
C-suite (256)
Cystic fibrosis (94)
Data (2166)
Decentralized trials (2)
Denatured (19)
Depression (52)
Diabetes (264)
Diagnostics (6160)
Digital health (14)
Diversity (5)
Diversity, equity & inclusion (38)
Drug discovery (122)
Drug pricing (103)
Drug shortages (27)
Duchenne muscular dystrophy (89)
Earnings (74012)
Editorial (38)
Employer branding (21)
Employer resources (135)
Events (100268)
Executive appointments (756)
FDA (16451)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (703)
Gene editing (103)
Generative AI (20)
Gene therapy (315)
GLP-1 (737)
Government (4341)
Grass and pollen (5)
Guidances (63)
Healthcare (17419)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (130)
Indications (27)
Infectious disease (2703)
Inflammatory bowel disease (138)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (92)
Interviews (533)
IPO (15031)
IRA (45)
Job creations (3655)
Job search strategy (1798)
Kidney cancer (11)
Labor market (23)
Layoffs (466)
Leadership (24)
Legal (7613)
Liver cancer (75)
Lung cancer (328)
Lymphoma (151)
Machine learning (6)
Management (53)
Manufacturing (298)
MASH (74)
Medical device (11570)
Medtech (11575)
Mergers & acquisitions (19031)
Metabolic disorders (697)
Multiple sclerosis (82)
NASH (23)
Neurodegenerative disease (105)
Neuropsychiatric disorders (32)
Neuroscience (1991)
NextGen: Class of 2025 (6083)
Non-profit (4202)
Now hiring (34)
Obesity (367)
Opinion (239)
Ovarian cancer (74)
Pain (94)
Pancreatic cancer (81)
Parkinson's disease (150)
Partnered (20)
Patents (230)
Patient recruitment (109)
Peanut (41)
People (57797)
Pharmaceutical (73)
Pharmacy benefit managers (13)
Phase I (19881)
Phase II (28544)
Phase III (21757)
Pipeline (1192)
Policy (143)
Postmarket research (2602)
Preclinical (8312)
Press Release (72)
Prostate cancer (105)
Psychedelics (37)
Radiopharmaceuticals (231)
Rare diseases (388)
Real estate (5472)
Recruiting (59)
Regulatory (21866)
Reports (25)
Research institute (2277)
Resumes & cover letters (375)
Rett syndrome (5)
RNA editing (4)
RSV (39)
Schizophrenia (78)
Series A (123)
Series B (77)
Service/supplier (6)
Sickle cell disease (54)
Special edition (11)
Spinal muscular atrophy (149)
Sponsored (29)
Startups (3290)
State (2)
Stomach cancer (14)
Supply chain (68)
Tariffs (40)
The Weekly (56)
Vaccines (665)
Venture capitalists (34)
Weight loss (248)
Women's health (26)
Worklife (18)
Date
Today (186)
Last 7 days (846)
Last 30 days (2530)
Last 365 days (31293)
2025 (10253)
2024 (33509)
2023 (37788)
2022 (48768)
2021 (52757)
2020 (51306)
2019 (44117)
2018 (33608)
2017 (31255)
2016 (30469)
2015 (35768)
2014 (29030)
2013 (24325)
2012 (25767)
2011 (26781)
2010 (24669)
Location
Africa (839)
Alabama (52)
Alaska (6)
Arizona (181)
Arkansas (13)
Asia (39786)
Australia (7341)
California (5536)
Canada (1948)
China (500)
Colorado (255)
Connecticut (245)
Delaware (138)
Europe (87031)
Florida (848)
Georgia (181)
Idaho (55)
Illinois (516)
India (24)
Indiana (280)
Iowa (7)
Japan (165)
Kansas (93)
Kentucky (23)
Louisiana (10)
Maine (64)
Maryland (841)
Massachusetts (4233)
Michigan (227)
Minnesota (338)
Mississippi (1)
Missouri (85)
Montana (26)
Nebraska (23)
Nevada (56)
New Hampshire (64)
New Jersey (1664)
New Mexico (22)
New York (1621)
North Carolina (933)
North Dakota (7)
Northern California (2419)
Ohio (181)
Oklahoma (9)
Oregon (33)
Pennsylvania (1247)
Puerto Rico (13)
Rhode Island (29)
South America (1152)
South Carolina (20)
South Dakota (1)
Southern California (2114)
Tennessee (94)
Texas (833)
United States (21356)
Utah (174)
Virginia (152)
Washington D.C. (51)
Washington State (509)
West Virginia (3)
Wisconsin (49)
652,807 Results for "kadmon corporation formerly known as kadmon pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Business
Sanofi Closes NY Kadmon Facility in Effort to Simplify Operations
Six months after acquiring Kadmon Holdings, pharma giant Sanofi is closing Kadmon’s New York facility. As part of the paring down, Sanofi is also laying off 25 employees at the location.
April 7, 2022
·
2 min read
·
Hannah Chudleigh
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Deals
Sanofi completes acquisition of Kadmon
Paris– November9, 2021 - Sanofi announced the completion of its acquisition of Kadmon Holdings, Inc.
November 9, 2021
·
5 min read
Press Releases
Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study
March 3, 2025
·
5 min read
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Business
Kadmon Provides Business Update and Reports Third Quarter 2021 Financial Results
Kadmon Holdings, Inc. provided a business update and reported financial and operational results for the third quarter of 2021.
November 4, 2021
·
14 min read
Deals
Sanofi to acquire Kadmon to further strengthen growth of transplant business
Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc. a biopharmaceutical company that discovers, develops, and markets transformative therapies for disease areas of significant unmet medical needs.
September 8, 2021
·
11 min read
Business
Kadmon Provides Business Update and Reports Second Quarter 2021 Financial Results
Kadmon Holdings, Inc. provided a business update and reported financial and operational results for the second quarter of 2021.
August 5, 2021
·
10 min read
Press Releases
Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates
May 2, 2025
·
15 min read
1 of 65,281
Next
